How Johnson & Johnson Dividends Survive a Steepening Yield Curve

In Episode 127 of Dividend Investing with Fexingo, Lucas and Luna break down why Johnson & Johnson's dividend is built to last even as the yield curve steepens. With the 10-year Treasury yield rising to 4.63% and the 2-year at 4.26%, investors worry that bonds are competing with dividend stocks. But JNJ's 2.3% weekly gain shows the market trusts its payout. The hosts walk through JNJ's balance sheet: $17 billion in operating cash flow last year, a payout ratio under 60%, and a triple-A credit rating. They contrast this with riskier high-yield plays like Altria, which pays over 8% but carries more debt. Lucas explains why the steepener actually favors defensive dividend growth, and Luna shares why she's watching JNJ's pharma pipeline for future dividend growth. No clickbait, just a clear case study in dividend safety. #DividendInvesting #JohnsonAndJohnson #YieldCurve #SteepeningCurve #DividendSafety #PayoutRatio #DefensiveStocks #BondVsDividends #JNJ #Finance #IncomeInvesting #DividendGrowth #CashFlow #CreditRating #Altria #FexingoBusiness #BusinessPodcast #July2026 Keep every episode free: buymeacoffee.com/fexingo